Serratia marcescens bacteremia after carotid endarterectomy and coronary artery bypass grafting

• Published in: Heart & lung Vol. 28; no. 4; pp. 293 - 294
• Main Authors: Demetriou, Chris A., Cunha, Burke A.
• Format: Journal Article
• Language: English
• Published: St. Louis, MO Mosby, Inc 01-07-1999; Mosby
• Subjects: Aged; Aged, 80 and over; Anti-Infective Agents - therapeutic use; Bacteremia - drug therapy; Bacteremia - microbiology; Biological and medical sciences; Coronary Artery Bypass - adverse effects; Cross Infection - drug therapy; Cross Infection - microbiology; Endarterectomy, Carotid - adverse effects; Humans; Levofloxacin; Male; Medical sciences; Ofloxacin - therapeutic use; Serratia Infections - drug therapy; Serratia marcescens - isolation & purification; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels; Human; Infection; Case study; Treatment; Aortocoronary; Bypass; Surgery; Carotid; Serratia marcescens; Bacteriosis; Bacteria; Complication; Endarteriectomy; Enterobacteriaceae
• ISSN: 0147-9563; 1527-3288
• DOI: 10.1016/S0147-9563(99)70076-2

Serratia Marcescens is a common, water-borne hospital colonizer. Respiratory secretions, wounds, and urine are frequently recognized areas of
Serratia colonization.
Serratia bacteremias usually occur nosocomially and are associated with high mortality and morbidity rates.
Serratia bacteremias may be primary or secondary from an identifiable source. Hospital-acquired
S marcescens bacteremias have no known source in half of the cases. We present a case of nosocomial primary
S marcescens bacteremia in a surgical patient successfully treated with levofloxacin. (Heart Lung
® 1999;28:293-4)